U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Duodenal ulcer

MedGen UID:
41670
Concept ID:
C0013295
Disease or Syndrome
Synonym: Duodenal ulcer (disease)
SNOMED CT: Duodenal ulcer (51868009); DU - Duodenal ulcer (51868009); Ulcer of duodenum (51868009); DUD - Duodenal ulcer disease (51868009); Duodenal ulcer disease (51868009)
 
HPO: HP:0002588
Monarch Initiative: MONDO:0005412

Definition

An erosion of the mucous membrane in a portion of the duodenum. [from HPO]

Term Hierarchy

Conditions with this feature

Duodenal ulcer, hyperpepsinogenemic 1
MedGen UID:
343701
Concept ID:
C1852008
Disease or Syndrome
Duodenal ulcer due to antral G-cell hyperfunction
MedGen UID:
338843
Concept ID:
C1852009
Disease or Syndrome
Tremor-nystagmus-duodenal ulcer syndrome
MedGen UID:
349908
Concept ID:
C1860860
Disease or Syndrome
A rare hyperkinetic movement disorder with characteristics of mild to severe, progressive essential tremor, nystagmus (principally horizontal), duodenal ulceration and a narcolepsy-like sleep disturbance. Refractive errors and cerebellar signs such as gait ataxia and adiadochokinesia may be associated. There have been no further descriptions in the literature since 1976.
Plasminogen deficiency, type I
MedGen UID:
369859
Concept ID:
C1968804
Disease or Syndrome
Congenital plasminogen deficiency is a rare autosomal recessive disorder characterized clinically by chronic mucosal pseudomembranous lesions consisting of subepithelial fibrin deposition and inflammation. The most common clinical manifestation is ligneous ('wood-like') conjunctivitis, a redness and subsequent formation of pseudomembranes mostly on the palpebral surfaces of the eye that progress to white, yellow-white, or red thick masses with a wood-like consistency that replace the normal mucosa. The lesions may be triggered by local injury and/or infection and often recur after local excision. Pseudomembranous lesions of other mucous membranes often occur in the mouth, nasopharynx, trachea, and female genital tract. Some affected children also have congenital occlusive hydrocephalus. A slightly increased female:male ratio has been observed (1.4:1 to 2:1) (Schuster and Seregard, 2003; Tefs et al., 2006). Type I plasminogen deficiency is characterized by decreased serum plasminogen activity, decreased plasminogen antigen levels, and clinical symptoms, whereas type II plasminogen deficiency, also known as 'dysplasminogenemia,' is characterized by decreased plasminogen activity with normal or slightly reduced antigen levels. Patients with type II deficiency are usually asymptomatic. Ligneous conjunctivitis and pseudomembranous formation has only been associated with type I plasminogen deficiency. Presumably, normal amounts of plasminogen antigen with decreased activity, as seen in type II, is sufficient for normal wound healing (Schuster and Seregard, 2003).
Coffin-Siris syndrome 1
MedGen UID:
482831
Concept ID:
C3281201
Disease or Syndrome
Coffin-Siris syndrome (CSS) is classically characterized by aplasia or hypoplasia of the distal phalanx or nail of the fifth and additional digits, developmental or cognitive delay of varying degree, distinctive facial features, hypotonia, hirsutism/hypertrichosis, and sparse scalp hair. Congenital anomalies can include malformations of the cardiac, gastrointestinal, genitourinary, and/or central nervous systems. Other findings commonly include feeding difficulties, slow growth, ophthalmologic abnormalities, and hearing impairment.
Spondylo-ocular syndrome
MedGen UID:
900371
Concept ID:
C4225412
Disease or Syndrome
Spondylo-ocular syndrome is a very rare association of spinal and ocular manifestations that is characterized by dense cataracts, and retinal detachment along with generalized osteoporosis and platyspondyly. Mild craniofacial dysphormism has been reported including short neck, large head and prominent eyebrows.
Hyper-IgE recurrent infection syndrome 1, autosomal dominant
MedGen UID:
1648470
Concept ID:
C4721531
Disease or Syndrome
STAT3 hyper IgE syndrome (STAT3-HIES) is a primary immune deficiency syndrome characterized by elevated serum IgE, eczema, and recurrent skin and respiratory tract infections, together with several nonimmune features. This disorder typically manifests in the newborn period with a rash (often diagnosed as eosinophilic pustulosis) that subsequently evolves into an eczematoid dermatitis. Recurrent staphylococcal skin boils and bacterial pneumonias usually manifest in the first years of life. Pneumatoceles and bronchiectasis often result from aberrant healing of pneumonias. Mucocutaneous candidiasis is common. Nonimmune features may include retained primary teeth, scoliosis, bone fractures following minimal trauma, joint hyperextensibility, and characteristic facial appearance, which typically emerges in adolescence. Vascular abnormalities have been described and include middle-sized artery tortuosity and aneurysms, with infrequent clinical sequelae of myocardial infarction and subarachnoid hemorrhage. Gastrointestinal (GI) manifestations include gastroesophageal reflux disease, esophageal dysmotility, and spontaneous intestinal perforations (some of which are associated with diverticuli). Fungal infections of the GI tract (typically histoplasmosis, Cryptococcus, and Coccidioides) also occur infrequently. Survival is typically into adulthood, with most individuals now living into or past the sixth decade. Most deaths are associated with gram-negative (Pseudomonas) or filamentous fungal pneumonias resulting in hemoptysis. Lymphomas occur at an increased frequency.
Menke-Hennekam syndrome 2
MedGen UID:
1676668
Concept ID:
C5193035
Disease or Syndrome
Menke-Hennekam syndrome-2 (MKHK2) is a congenital disorder characterized by variable impairment of intellectual development and facial dysmorphisms. Feeding difficulties, autistic behavior, recurrent upper airway infections, and hearing impairment are also frequently seen. Although mutations in the same gene cause Rubinstein-Taybi syndrome-2 (RSTS2; 613684), patients with MKHK1 do not resemble the striking phenotype of RSTS2. For a discussion of genetic heterogeneity of Menke-Hennekam syndrome, see MKHK1 (618332).
Immunodeficiency 82 with systemic inflammation
MedGen UID:
1781752
Concept ID:
C5543581
Disease or Syndrome
Immunodeficiency-82 with systemic inflammation (IMD82) is a complex autosomal dominant immunologic disorder characterized by recurrent infections with various organisms, as well as noninfectious inflammation manifest as lymphocytic organ infiltration with gastritis, colitis, and lung, liver, CNS, or skin disease. One of the more common features is inflammation of the stomach and bowel. Most patients develop symptoms in infancy or early childhood; the severity is variable. There may be accompanying fever, elevated white blood cell count, decreased B cells, hypogammaglobulinemia, increased C-reactive protein (CRP; 123260), and a generalized hyperinflammatory state. Immunologic workup shows variable B- and T-cell abnormalities such as skewed subgroups. Patients have a propensity for the development of lymphoma, usually in adulthood. At the molecular level, the disorder results from a gain-of-function mutation that leads to constitutive and enhanced activation of the intracellular inflammatory signaling pathway. Treatment with SYK inhibitors rescued human cell abnormalities and resulted in clinical improvement in mice (Wang et al., 2021).
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder
MedGen UID:
1799074
Concept ID:
C5567651
Disease or Syndrome
Recurrent gastrointestinal ulceration with dysfunctional platelets (GURDP) is an autosomal recessive disorder characterized by onset of severe gastrointestinal mucosal ulceration in early childhood. Affected individuals may have secondary iron deficiency anemia or malnourishment. Studies of platelet aggregation show a functional defect associated with decreased thromboxane-A2 production and decreased eicosanoid biosynthesis. The gastrointestinal disease is believed to result from decreased or absent production of prostaglandins that protect the gut mucosa (summary by Adler et al., 2008 and Faioni et al., 2014).

Professional guidelines

PubMed

Roy AJ, Maut C, Gogoi HK, Ahmed SI, Kashyap A
Curr Drug Discov Technol 2023;20(3):e121222211869. doi: 10.2174/1570163820666221212142221. PMID: 36515023
de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, Neves PHM, de Melo FF
World J Gastroenterol 2019 Oct 7;25(37):5578-5589. doi: 10.3748/wjg.v25.i37.5578. PMID: 31602159Free PMC Article
Satoh K, Yoshino J, Akamatsu T, Itoh T, Kato M, Kamada T, Takagi A, Chiba T, Nomura S, Mizokami Y, Murakami K, Sakamoto C, Hiraishi H, Ichinose M, Uemura N, Goto H, Joh T, Miwa H, Sugano K, Shimosegawa T
J Gastroenterol 2016 Mar;51(3):177-94. Epub 2016 Feb 15 doi: 10.1007/s00535-016-1166-4. PMID: 26879862

Recent clinical studies

Etiology

Malik M, Magsi AM, Parveen S, Khan MI, Iqbal M
J Pak Med Assoc 2023 Jul;73(7):1506-1510. doi: 10.47391/JPMA.4768. PMID: 37469068
Misciagna G, Cisternino AM, Freudenheim J
Dig Liver Dis 2000 Aug-Sep;32(6):468-72. doi: 10.1016/s1590-8658(00)80002-x. PMID: 11057920
Dore MP, Graham DY
Baillieres Best Pract Res Clin Gastroenterol 2000 Feb;14(1):97-107. doi: 10.1053/bega.1999.0061. PMID: 10749091
Tennant C
Aust N Z J Psychiatry 1988 Jun;22(2):195-201. doi: 10.3109/00048678809158960. PMID: 3041960
Goldberg SJ, Smith CL, Connell AM
Am J Gastroenterol 1976 Jan;65(1):41-5. PMID: 1274929

Diagnosis

Francavilla ML, Pollock AN
Pediatr Emerg Care 2017 Mar;33(3):219-220. doi: 10.1097/PEC.0000000000001060. PMID: 28248764
Newton EB, Versland MR, Sepe TE
World J Gastroenterol 2008 Aug 28;14(32):4995-9. doi: 10.3748/wjg.14.4995. PMID: 18763280Free PMC Article
Glick SN
Radiol Clin North Am 1994 Nov;32(6):1259-74. PMID: 7972712
Pounder RE
Aliment Pharmacol Ther 1987;1 Suppl 1:439S-446S. doi: 10.1111/j.1365-2036.1987.tb00654.x. PMID: 2979695
Spiro HM
J Clin Gastroenterol 1982 Feb;4(1):9-10. doi: 10.1097/00004836-198202000-00001. PMID: 7077066

Therapy

Bohidar NP, Krishna K, Panda BK, Patel C
Trop Gastroenterol 2013 Apr-Jun;34(2):95-8. doi: 10.7869/tg.2012.105. PMID: 24377157
Korman MG, Bolin TD, Szabo S, Hunt RH, Marks IN, Glise H
J Gastroenterol Hepatol 1994 Jul-Aug;9(4):412-5. doi: 10.1111/j.1440-1746.1994.tb01264.x. PMID: 7948825
Watkinson G, Hopkins A, Akbar FA
Postgrad Med J 1988;64 Suppl 1:60-77. PMID: 3138682
McLean AJ, Harrison PM, Ioannides-Demos L, Byrne AJ, McCarthy P, Dudley FJ
Aust N Z J Med 1985 Jun;15(3):367-74. doi: 10.1111/j.1445-5994.1985.tb04065.x. PMID: 3904700
Med Lett Drugs Ther 1982 Dec 24;24(625):111-3. PMID: 6292677

Prognosis

Chiu PW, Sung JJ
Curr Opin Gastroenterol 2010 Sep;26(5):425-8. doi: 10.1097/MOG.0b013e32833d1746. PMID: 20703110
Fujishiro M, Abe N, Endo M, Kawahara Y, Shimoda R, Nagata S, Homma K, Morita Y, Uedo N
Dig Endosc 2010 Jul;22 Suppl 1:S9-14. doi: 10.1111/j.1443-1661.2010.00961.x. PMID: 20590780
Escobar MA, Ladd AP, Grosfeld JL, West KW, Rescorla FJ, Scherer LR 3rd, Engum SA, Rouse TM, Billmire DF
J Pediatr Surg 2004 Jun;39(6):867-71; discussion 867-71. doi: 10.1016/j.jpedsurg.2004.02.025. PMID: 15185215
Tytgat GN
Scand J Gastroenterol Suppl 1995;210:70-2. doi: 10.3109/00365529509090275. PMID: 8578212
Kuipers EJ, Thijs JC, Festen HP
Aliment Pharmacol Ther 1995;9 Suppl 2:59-69. PMID: 8547530

Clinical prediction guides

Malik M, Magsi AM, Parveen S, Khan MI, Iqbal M
J Pak Med Assoc 2023 Jul;73(7):1506-1510. doi: 10.47391/JPMA.4768. PMID: 37469068
Okamoto T, Okamoto S, Yamamoto K, Takasu A, Murashima Y, Fukui S, Fukuda K
Eur J Gastroenterol Hepatol 2023 Sep 1;35(9):955-961. Epub 2023 Jun 22 doi: 10.1097/MEG.0000000000002585. PMID: 37395188
García-Altés A, Rota R, Barenys M, Abad A, Moreno V, Pons JM, Piqué JM
Eur J Gastroenterol Hepatol 2005 Jul;17(7):709-19. doi: 10.1097/00042737-200507000-00004. PMID: 15947547
Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Luzi C, Andreoli A
J Psychosom Res 1993 Jan;37(1):19-32. doi: 10.1016/0022-3999(93)90120-5. PMID: 8421257
Hui WM, Lam SK
Dig Dis 1989;7(1):51-60. doi: 10.1159/000171206. PMID: 2647323

Recent systematic reviews

Clinch D, Damaskos D, Di Marzo F, Di Saverio S
J Trauma Acute Care Surg 2021 Oct 1;91(4):748-758. doi: 10.1097/TA.0000000000003357. PMID: 34254960
Huang HB, Jiang W, Wang CY, Qin HY, Du B
Crit Care 2018 Jan 28;22(1):20. doi: 10.1186/s13054-017-1937-1. PMID: 29374489Free PMC Article
Prescrire Int 2016 Jan;25(167):18-23. PMID: 26942258
Tomtitchong P, Siribumrungwong B, Vilaichone RK, Kasetsuwan P, Matsukura N, Chaiyakunapruk N
Helicobacter 2012 Apr;17(2):148-52. doi: 10.1111/j.1523-5378.2011.00928.x. PMID: 22404446
Leontiadis GI, Moayyedi P, Ford AC
BMJ Clin Evid 2009 Oct 1;2009 PMID: 21718575Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...